Author:
Rhiem Kerstin,Schmutzler Rita K.
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Robert Koch-Institut (2021) die Gesellschaft der epidemiologischen Krebsregister in Deutschland. In: Robert Koch-Institut (Hrsg) Krebs in Deutschland für 2017/2018 (13. Ausgabe). e. V., Berlin, Germany
2. Rhiem K, Bücker-Nott H‑J, Hellmich M et al (2019) Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort. Breast J 25:455–460
3. Kast K, Rhiem K, Wappenschmidt B et al (2016) Prevalence of BRCA 1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53:465–471
4. Hauke J, Horvath J, Gross E et al (2018) Gene panel testing of 5589 BRCA 1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German consortium for hereditary breast and ovarian cancer. Cancer Med 7:1349–1358
5. Mavaddat N, Michailidou K, Dennis J et al (2019) Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet 104:21–34